Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes

Download All

Listen as faculty review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD. Review treatment strategies for managing patients with uILD and hear expert perspectives on the clinical trial findings of emerging treatments.

Topics Include:

  • Appropriate Classification
  • Challenges With uILD Diagnosis, Prognosis, and Follow-up
  • Treatments: Evidence for and Against Corticosteroids, Immunotherapies, and Antifibrotics
  • Questions and Answers
Toby Maher, MD, PhD, FRCP
Mary Beth Scholand, MD

Listen as faculty review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD. Review treatment strategies for managing patients with uILD and hear expert perspectives on the clinical trial findings of emerging treatments.

Toby Maher, MD, PhD, FRCP Mary Beth Scholand, MD Released: August 5, 2021
Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue